Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

VANQUISH Introduces DIGITAL HEADACHE Brand Pain Reliever For Modern Day Headaches


EDISON, N.J., July 14, 2020 /PRNewswire/ -- DSE Healthcare Solutions recharges its legacy brand VANQUISH® to meet the needs of today's consumer with the launch of VANQUISH® DIGITAL HEADACHEtm Brand Pain Reliever. The company set its sights on 2020 to reintroduce the powerful pain reliever to a new generation of headache sufferers with digital eyestrain and device fatigue on the rise. That trend shows no sign of slowing. In fact, a recent report suggests people with conditions like headaches and neck pain are experiencing symptoms more often due in large part to a dramatic increase in screen time with more than 75 percent of those surveyed acknowledging increased use of digital devices during this pandemic.1

VANQUISH has been fighting tough headaches with proven efficacy for over 50 years and was one of the first pain reliever brands to combine a unique formulation of aspirin, acetaminophen and caffeine. Now, VANQUISH DIGITAL HEADACHE Brand Pain Reliever is well positioned to go to work for millennials by addressing the headache, neck, eye and shoulder pain that can result from heavy screen time.

"As a health and wellness company, our goal is to offer solutions to today's consumers' needs, as well as understand their new daily routines," said Michele Muhammad, chief marketing officer of DSE Healthcare Solutions. "We encourage digital wellness and making practical changes to limit screen time where possible, but we understand that may be more challenging now than ever.  We're proud to offer Vanquish for those hard-working people who need all the help they can get."

VANQUISH DIGITAL HEADACHE Brand Pain Reliever is resonating with a new audience, one that may have first learned about VANQUISH from their parents or grandparents. The brand is reaching today's digital headache sufferers online with a digital-first marketing strategy along with helpful tips and resources like a Digital Fatigue Quiz on its website. The company released a video ad that flips traditional COVID-19 messaging on its head and embraces relatable scenarios to tackle the pandemic without even mentioning it. The video ranked number four on Ad Age's recent top 10 "Most Viewed Video Ads" list. It resonated because it spoke to the real concern of people spending more time on their devices and screens than ever before.

VANQUISH DIGITAL HEADACHE Brand Pain Reliever delivers effective ingredients at just the right levels that may offer fast relief from digital headaches and pain and it is also effective on backaches, muscle aches, arthritis and more. Save yourself a headache and get VANQUISH DIGITAL HEADACHE Brand Pain Reliever for the next time digital pain strikes.

VANQUISH DIGITAL HEADACHE Brand Pain Reliever is now available exclusively on Amazon or VanquishHeadacheRelief.com. Follow us on social and join the conversation online using hashtag #VanquishHeadacheRelief.  

  1. National Headache Foundation; Report: Screen Time and Neurological Symptoms Rising Due to COVID-19; https://headaches.org/2020/05/14/screen-time-covid-19/

About DSE Healthcare Solutions

DSE Healthcare Solutions, LLC (DSE) is a privately held consumer healthcare company.  We manufacture and market a portfolio of brands primarily within the vitamin, digestive health and skincare categories. Our collection of legacy, challenger brands set us apart.  We proudly rejuvenate enduring, no-frills health and wellness brands to introduce them to new generations. Discover our nostalgic brand stories and see how authenticity, a focus on quality ingredients, and a commitment to our values still meets contemporary needs. When it comes to everyday health and wellness, we believe simpler is better - and always will. DSE is a proud member of CRN, the Council for Responsible Nutrition, and CHPA, the oldest trade association in the US focused on OTC (over the counter) products.

MEDIA CONTACT: Alexis Valenti[email protected], (312) 613-4822

SOURCE DSE Healthcare Solutions


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: